Artificial human Met agonists based on macrocycle scaffolds
about
A current perspective on applications of macrocyclic-peptide-based high-affinity ligandsMET-activating Residues in the B-repeat of the Listeria monocytogenes Invasion Protein InlB.Targeting kinase signaling pathways with constrained peptide scaffolds.In Vitro Selection Combined with Ribosomal Translation Containing Non-proteinogenic Amino Acids.A RaPID way to discover nonstandard macrocyclic peptide modulators of drug targets.Different growth and metastatic phenotypes associated with a cell-intrinsic change of Met in metastatic melanoma.Hepatocyte growth factor/MET in cancer progression and biomarker discoveryNew Modalities for Challenging Targets in Drug Discovery.Hepatocyte growth factor and Met in drug discovery.Oligonucleotide-Based Mimetics of Hepatocyte Growth Factor.Cyclic peptide oral bioavailability: Lessons from the past.Max-Bergmann award lecture:A RaPID way to discover bioactive nonstandard peptides assisted by the flexizyme and FIT systems.PSL Chemical Biology Symposia First 2016 Edition: When Chemistry and Biology Share the Language of Discovery.A Fluorescent Imaging Probe Based on a Macrocyclic Scaffold That Binds to Cellular EpCAM.Kinetics of tRNA(Pyl) -mediated amber suppression in Escherichia coli translation reveals unexpected limiting steps and competing reactions.Non-competitive cyclic peptides for targeting enzyme-substrate complexes.Cellular signaling and gene expression profiles evoked by a bivalent macrocyclic peptide that serves as an artificial MET receptor agonist
P2860
Q28072407-BA142E83-2384-458D-A836-C292DC360064Q30394618-6F14281A-AD09-4635-92DA-A8434697D067Q30398451-CD5228EE-A48E-4F50-BBE1-204CF6F549A9Q35896248-66B18679-A14A-4AAA-9B49-7B30AEF47112Q36250421-85536A24-3148-4531-BB27-C83B124A03B9Q37688612-D71C0781-8F16-429D-864F-BBF1AE958F0AQ37735624-8F5FE3F5-CE8C-4DAD-8B40-2B61D7FD7679Q38289100-459E6DDF-8C90-4C28-8346-0C03FA5DD3C1Q38377273-A2B520C6-2937-416E-9DEA-B9946E4A2E4CQ38817809-C2DB5DCE-B23F-410F-A74D-597F8AF6DCB3Q38834152-6F275A07-A3CF-4197-8E17-14A42F2EAC5BQ48262298-60CA1E80-8921-4FBE-B5F8-D9C0DE476234Q48329819-1F4FF1FE-D4BE-4A25-9ADB-75F41911B6D4Q51651534-94ABB74F-D646-46AB-BAF6-7AD6620903CDQ53355004-96156D4E-FB97-45B1-AD39-A4BBB9DB7714Q55083155-E9C57623-7CE3-4A07-B5FA-352059648FF0Q58602771-563B262D-9F73-4682-891A-B2372844A8A8
P2860
Artificial human Met agonists based on macrocycle scaffolds
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Artificial human Met agonists based on macrocycle scaffolds
@ast
Artificial human Met agonists based on macrocycle scaffolds
@en
type
label
Artificial human Met agonists based on macrocycle scaffolds
@ast
Artificial human Met agonists based on macrocycle scaffolds
@en
prefLabel
Artificial human Met agonists based on macrocycle scaffolds
@ast
Artificial human Met agonists based on macrocycle scaffolds
@en
P2093
P2860
P356
P1476
Artificial human Met agonists based on macrocycle scaffolds
@en
P2093
Hiroaki Suga
Katsuya Sakai
Kenichiro Ito
Naoya Ozawa
Tomohisa Hatta
Yoshinori Suzuki
P2860
P2888
P356
10.1038/NCOMMS7373
P407
P577
2015-03-11T00:00:00Z